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Proteomic comparisons of 
opaque and transparent variants 
of Streptococcus pneumoniae by 
two dimensional-differential gel 
electrophoresis
Melissa H. Chai1, Florian Weiland2,3,4, Richard M. Harvey1, Peter Hoffmann2,3, Abiodun D. 
Ogunniyi1,5 & James C. Paton1
Streptococcus pneumoniae (the pneumococcus) is a human pathogen, accounting for massive global 
morbidity and mortality. Although asymptomatic colonization of the nasopharynx almost invariably 
precedes disease, the critical determinants enabling pneumococcal progression from this niche to 
cause invasive disease are poorly understood. One mechanism proposed to be central to this transition 
involves opacity phase variation, whereby pneumococci harvested from the nasopharynx are typically 
transparent, while those simultaneously harvested from the blood are opaque. Here, we used two 
dimensional-differential gel electrophoresis (2D-DIGE) to compare protein expression profiles of 
transparent and opaque variants of 3 pneumococcal strains, D39 (serotype 2), WCH43 (serotype 4) and 
WCH16 (serotype 6A) in vitro. One spot comprising a mixture of capsular polysaccharide biosynthesis 
protein and other proteins was significantly up-regulated in the opaque phenotype in all 3 strains; other 
proteins were differentially regulated in a strain-specific manner. We conclude that pneumococcal phase 
variation is a complex and multifactorial process leading to strain-specific pathogenicity.
Streptococcus pneumoniae (the pneumococcus) is a formidable human pathogen, responsible for massive global 
morbidity and mortality. It causes a broad spectrum of diseases including pneumonia, meningitis, bacteraemia 
and otitis media, and accounts for more deaths worldwide than any other single pathogen1. In developing coun-
tries, up to 1 million children under 5 years of age die each year from pneumonia, of which S. pneumoniae is the 
single commonest cause, accounting for 20% of all deaths in this age group1. Asymptomatic nasopharyngeal 
carriage is an essential first step in the pathogenesis of disease2, and pneumococcal strains differ markedly in 
their capacity to invade other tissues from this niche. While certain serotypes and/or clonal groups are more often 
isolated from the nasopharynx, and others more often isolated from sterile sites (such as blood), the underlying 
genomic/phenomic differences responsible for these variations between strains are yet to be fully elucidated.
Studies of the phenomenon of colony opacity phase variation in S. pneumoniae are providing clues regarding 
genes that might be central to the transition from carriage to invasive disease. When S. pneumoniae colonies 
growing on agar plates are observed under oblique transmitted light, two distinct morphologies, described as 
“opaque” (O) and “transparent” (T), are observed3. When opaque colonies are subcultured, a small proportion of 
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them spontaneously change to the transparent form, and vice versa3, 4. Interestingly, the T forms have an enhanced 
capacity to colonize the nasopharynx relative to O variants of the same strain, which correlates with increased 
in vitro adherence to epithelial cells, while the opaque form is associated with massively increased virulence in 
animal models of systemic disease4, 5.
The relevance of phase variation to the pathogenesis of human disease is supported by the finding that when 
apparently identical S. pneumoniae strains are isolated simultaneously from the nasopharynx and blood of 
patients with invasive disease, those from the former niche are largely in the transparent phase, whilst those 
from the latter are almost all opaque3. Recently, we reported a random six-phase genetic rearrangement in a 
type I restriction-modification (RM) system (SpnD39III) with distinct methylation patterns resulting in differ-
ential gene expression profiles6. The variants also displayed distinct phenotypic changes, including opacity phase 
variation differences, which have a major impact on pneumococcal virulence in mice. Variation in the levels of 
expression of pneumococcal capsular polysaccharide (CPS) and certain surface proteins between the two forms 
has also been reported7. However, colony opacity variation still occurs in unencapsulated mutants, suggesting 
that the varying amount of capsule was not entirely responsible for the colony opacity phenotype3. Interestingly, 
T variants exhibit a higher teichoic acid to capsule ratio4, an observation that could be of relevance given that 
teichoic acid is important for the anchorage of choline-binding proteins to the pneumococcal surface, thereby 
enhancing colonization of the nasopharynx8, 9. Phosphorylcholine present on the teichoic and lipoteichoic acid 
residues of the cell wall also interact with the platelet-activating factor receptor on respiratory epithelium, facili-
tating adherence to the nasopharynx8, 10.
We reasoned that the inconsistencies in the literature with regard to distinct expression patterns of proteins 
between pneumococcal colony opacity variants3, 7, 11 could have arisen because the pneumococcal strains and 
analytical techniques in each of those studies were different. In order to gain further insight into the pheno-
typic differences that underpin colony opacity variation in S. pneumoniae, we used 2-dimensional differential 
gel electrophoresis (2D-DIGE) to carry out a comprehensive comparison of protein expression profiles of T and 
O variants of 3 well-characterized pneumococcal strains: D39 (serotype 2), WCH43 (serotype 4) and WCH16 
(serotype 6A). These strains display distinct pathogenicity profiles: D39 causes severe pneumonia and high-grade 
bacteremia, WCH43 demonstrates the “classical” disease progression from the nasopharynx to the lungs and 
dissemination to blood and then to the brain, while WCH16 seems to progress directly to the brain with minimal 
lung and blood involvement12–14. These distinct characteristics make these strains ideal for our study. We hypoth-
esize that our analyses will identify proteins common to T and O variants of the 3 strains, while also accentuating 
their differences.
Results
Identification of opaque and transparent variants. Pure O and T working stocks of D39, WCH16 
and WCH43 were selected on THY-catalase plates based on their appearance under oblique, transmitted light as 
described in Methods. We observed that the O colonies are typically of convex elevation, compared with those of 
T form, which have umbonate elevation, exhibiting a doughnut-like appearance (Fig. 1). We also found that the 
strains have markedly different incubation times by which the colony opacity could easily be observed: 18 hours 
for D39, 24 hours for WCH16, and 36 hours for WCH43.
Analysis of differential protein expression profiles. To detect differentially expressed proteins between 
the O and T phenotype of the 3 strains, three independent DIGE experiments were performed, as described in 
Methods.
D39. The gel image data from the comparison of the T (n = 4) and O variants (n = 4) of D39 by DIGE was pro-
cessed by DeCyder. Spot patterns on the individual gel images of D39 were matched against a single master gel to 
ensure that all spots across the different gel images had the same reference number. A total of 982 protein spots 
were detected on the master gel, 602 of these spots were present in 75% of the spot maps (9 out of 12). Univariate 
statistical testing detected 65 differentially expressed spots with a p-value < 0.05. Of the 65 proteins, 37 protein 
spots were detected to be up-regulated in the O variant, while 28 protein spots were up-regulated in the T variant. 
The average fold-changes were between 10.9 (up-regulated in the O variant) and 15.8 (up-regulated in the T var-
iant) (Fig. 2a; Supplementary Fig. S1). At a significance level α = 0.05, the q-value extended false discovery rate 
(FDR) was calculated to be 13%. Post-hoc power calculation resulted in the ability to detect a fold-change of 2.5 
and above with at least 80% probability.
WCH16. Detection of differentially expressed proteins between the O (n = 4) and T variants (n = 4) of WCH16 
was performed as described for D39 above. In total, 1168 protein spots were detected on the master gel, and 674 
of these could be detected across 75% of the spot maps. Statistical testing detected 73 proteins as differentially 
expressed with a significance level α = 0.05. Of these, 46 protein spots were up-regulated in the O variant and 
27 protein spots were up-regulated in the T variant. Average fold-changes were calculated to be between 3.7 
(up-regulated in the O variant) and 4.9 (up-regulated in the T variant) (Fig. 2b; Supplementary Fig. S2). The cor-
responding q-value extended FDR was calculated to be 66%. Post-hoc power calculation resulted in the ability to 
detect fold-changes of 2.1 and above with at least 80% probability.
WCH43. The O (n = 4) and T (n = 4) variants of WCH43 were also compared for differential protein expression 
as described above. On the master gel, 1285 protein spots could be detected of which 879 were present in 75% 
of all spot maps. The statistical testing resulted in 183 differentially expressed proteins, with a cut-off value of 
α = 0.05. As with the other S. pneumoniae strains investigated in this study, there were more up-regulated protein 
spots in the O variant (n = 118) than in the T variant (n = 65). The q-value extended FDR for this significance 
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level of α = 0.05 was 11%. Post-hoc power was calculated and resulted in the ability to detect a fold-change of 2.5 
and above with at least 80% probability. The average fold-change of the differentially expressed proteins ranged 
between 7.5 (up-regulated in the O variant) and 18.2 (up-regulated in the T variant) (Fig. 2c; Supplementary 
Fig. S3).
Pneumococcal strains exhibit different protein expression profiles. To examine if there is a com-
mon pathway of regulation between the O and T phenotypes of the 3 pneumococcal strains, up to 20 protein spots 
which were substantially differentially regulated (with a minimum of 2-fold change between the two phenotypes) 
were subjected to identification by mass spectrometry. In this analysis, the proteins identified as up-regulated 
in the O variant of D39 include pyruvate oxidase (SpxB; GI Accession No. 15900627; 3-fold), and bifunctional 
acetaldehyde-CoA/alcohol dehydrogenase (GI Accession No. 15903879; 11-fold), whereas the protein identified 
as up-regulated in the T variant include glyceraldehyde-3-phosphate dehydrogenase (GAPDH; GI Accession 
No. 15901835; 16-fold) and lactate dehydrogenase [GI Accession No. 4138534; 3-fold] (Supplementary Tables S1 
and S2). Generally, fewer proteins were significantly differentially expressed between the O and T variants of 
Figure 1. Colony morphology of various S. pneumoniae strains and their variants grown on clear media 
(THY) supplemented with catalase. Images were captured using Nikon SMZ1000 on a dissecting microscope 
and viewed through cellSens software. (a) D39 opaque; (b) D39 transparent; (c) WCH16 opaque; (d) WCH16 
transparent; (e) WCH43 opaque; (f) WCH43 transparent.
Figure 2. 2D-DIGE analysis of protein lysates of a mixture of opaque and transparent variants of S. pneumoniae 
D39 (a), WCH16 (b) and WCH43 (c), highlighting differentially-regulated proteins between the variants. 
Images show false-color overlay of Cy2, Cy3 and Cy5 channels. Proteins with different signal intensities are 
shown either in green (Cy3) or red (Cy5) color, where yellow color indicate a similar amount of protein on the 
representative gels.
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4Scientific RepoRts | 7: 2453  | DOI:10.1038/s41598-017-02465-x
WCH16, compared to D39 variants. Notably, guanosine 5′-monophosphate oxidoreductase (GuaC; GI Accession 
No. 169833329; 4-fold) and maltose operon transcriptional repressor (GI Accession No. 15901927; 2-fold) were 
significantly up-regulated in the O variant of WCH16, while fructose-bisphosphate aldolase (Fba; GI Accession 
No. 15900513; 4-fold) and a branched chain amino acid transport ABC transporter substrate-binding protein 
(GI Accession No. 237650408; 3-fold) were significantly up-regulated in the T variant (Supplementary Tables S1 
and S3). The significantly up-regulated proteins in the O variant of WCH43 include formate acetyltransferase 
(GI Accession No. 15900375; 6-fold), fructose-bisphosphate aldolase (Fba; GI Accession No. 15900513; 5-fold) 
and anaerobic ribonucleoside triphosphate reductase (NrdD; GI Accession No. 15900138; 7-fold). In the T 
variant, proteins identified as up-regulated include glyceraldehyde-3-phosphate dehydrogenase (GAPDH; GI 
Accession No. 15901835; 8-fold) and ribose-phosphate pyrophosphokinase (GI Accession No. 15899974; 7-fold) 
(Supplementary Tables S1 and S4).
In order to reduce the dimensionality of the 2D-DIGE data, we applied principal components analysis (PCA) 
to the protein expression patterns between the O and T variants of the 3 strains. Our PCA plots show that the O 
and T variants of D39 are separated in the first principal component (PC), which accounts for 42.7% of overall 
variability of the dataset (Fig. 3). However, there was no linear separation of the O and T variants of WCH16 in 
the first nine PCs, while separation of the O and T variants of WCH43 was observed in the first PC, accounting 
for 39.9% of overall variability of the data.
As a direct comparison of the three independent DIGE experiments was not possible due to non-congruent 
spot patterns between D39, WCH16 and WCH43, a second DIGE experiment was conducted to interrogate for 
Figure 3. Principal component analysis of DIGE data from four independent experiments. (a) Transparent and 
opaque variants of strain D39 are separated in the first principal component (PC), representing 42.7% of overall 
variability of the dataset; (b) No linear separation of transparent and opaque variants of strain WCH16 in the 
first nine PCs (only the first two shown); (c) Separation of transparent and opaque variants of strain WCH43 
in the first PC, representing 39.9% of overall variability of the data. (d) Data from DIGE experiment including 
all three strains. Clustering of strains can be observed, however only separation of WCH43 transparent and 
opaque strains in the first PC. Circles around different strains are arbitrary in their shape and size and are for 
visualization only.
www.nature.com/scientificreports/
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identical pattern of protein regulation (11-055). Only spot 393 was consistently statistically significantly regulated 
between the O and T phenotype in all three strains (Fig. 4). Proteins contained in this spot were identified by 
mass spectrometry as adenylosuccinate synthetase, UDP-N-acetylmuramate–L-alanine ligase, ATP-dependent 
Clp protease ATP-binding subunit, 30S ribosomal protein S1 and capsular polysaccharide biosynthesis protein 
Cps4J (Supplementary Table S1).
SpxB analysis. A previous study had reported lower SpxB expression in O variants of S. pneumoniae sero-
types 6B and 9 V7, which contrasts with our findings with the O variant of D39. Therefore, in order to further 
assess the impact of SpxB expression on colony opacity, the spxB gene was deleted from the O and T variants of 
D39 by targeted deletion replacement mutagenesis using overlap PCR15. Both O and T spxB mutant derivatives 
of D39 appeared larger, rounder and were more of O variant morphology on THY-catalase plates compared to 
D39O wild-type (D39O WT) (Fig. 5). Since the deletion of spxB in the variants appeared to produce markedly 
more O colonies, the spxB gene from D39O was cloned into plasmid pAL3 and used to transform D39O for 
ectopic expression. The resultant mutant, D39O-pAL3::spxB, had the same colony phenotype compared to D39O 
WT (Fig. 5). Interestingly, quantitative Western blotting of whole cell lysates from D39O, WCH16O, WCH43O 
and their respective T variants using mouse anti-SpxB serum showed no apparent difference in the amount of 
SpxB produced by any of the variants (Fig. 6).
GAPDH activity is increased in T variants of D39 and WCH43. Our proteomic data showed that 
GAPDH was up-regulated in the T variant of D39 and up-regulated in 4 out of 5 GAPDH spots in the T variant 
of WCH43. However, GAPDH type 1 was up-regulated in the O variant of WCH16. In order to investigate these 
differences, the GAPDH activity between the O and T variants of D39, WCH16 and WCH43 were compared as 
described in Methods. For D39 and WCH43, the GAPDH activity in the T variant was significantly higher (about 
1.5-fold) compared to its O counterpart, while there was no significant difference in GAPDH activity between the 
O and T variants of WCH16 (Table 1).
Quantitative Western Blot Analysis of Various Proteins shows no consistent regulation. It 
was reported previously that O and T variants express different amounts of certain pneumococcal virulence 
factors and proteins involved in metabolism3, 7. Therefore, the expression levels of 14 pneumococcal proteins 
of the 2 variants of D39, WCH16 and WCH43 was evaluated by quantitative Western blotting of cell lysates 
using protein-specific mouse polyclonal antisera. Of these, 4 proteins (pyruvate kinase (Pyk), neuraminidase A 
(NanA), pneumolysin (Ply) and pneumococcal histidine triad protein D (PhtD) showed significant differences in 
the expression levels between the 2 variants in at least one of the three strains (Fig. 7). Interestingly, none of the 
proteins was shown to be consistently up-regulated in a particular variant in all 3 strains, suggesting that these 
proteins could play distinct roles in the physiology of different pneumococcal strains.
Discussion
The ability of respiratory pathogens such as Haemophilus influenzae and Neisseria meningitidis to disseminate 
from the nasopharynx to deeper host tissues to cause invasive disease has been shown to be dependent on their 
ability to reversibly adapt to changes in the microenvironment16–19. For S. pneumoniae, the phenomenon of 
opacity phase variation, first described over 2 decades ago3, was suggested to play a critical role in pneumo-
coccal pathogenesis, adaptation to different host microenvironments20 as well as host-pathogen interaction. It 
was demonstrated (and also subsequently) that when apparently identical S. pneumoniae strains are isolated 
Figure 4. 3D view of protein spot 393 in all three strains, upper view; opaque variant, lower view; transparent 
variant. Right side: Expression profile of spot 393 in all three strains.
www.nature.com/scientificreports/
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Figure 5. Colony morphology of various D39 SpxB mutants. Strains were streaked for single colonies on 
THY+ catalase agar plates and images were captured using Nikon SMZ1000 on a dissecting microscope and 
viewed through cellSens software. D39O, strain D39 opaque; D39T, strain D39 transparent; D39OΔspxB, 
D39O spxB mutant; D39TΔspxB, D39T spxB mutant; D39O:spxB over-express, D39O SpxB over-expression 
SpxB from D39T using a plasmid with constitutively expressing promoter; D39TΔspxB back-transform (T), 
D39TΔspxB with spxB from strain D39T re-inserted back; D39OΔspxB back-transform (O), D39OΔspxB with 
spxB from strain D39O re-inserted back; D39TΔspxB back-transform (O), D39TΔspxB with spxB from strain 
D39O re-inserted back; D39OΔspxB back-transform (T), D39OΔspxB with spxB from strain D39T re-inserted 
back.
Figure 6. Quantitative Western blot analysis of phenotypic variants against anti-SpxB mouse anti-serum. Equal 
amount of whole cell lysates were added to each well. Two biological replicates of each strain and their variants 
were compared. Lanes 1–2, D39 opaque; lanes 3–4, D39 transparent; lanes 5–6, WCH16 opaque; lanes 7–8 
WCH16 transparent; lanes 9–10, WCH43 opaque; lanes 11–12, WCH43 transparent.
www.nature.com/scientificreports/
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simultaneously from the nasopharynx and blood of patients with invasive disease, those from the nasopharynx 
are largely in the T phase, whilst those from the blood are almost exclusively in the O phase3–5, 13. While it has been 
demonstrated that the O variants express more capsule (and thus relatively less teichoic acid) than the T variant3, 7, 
phase variation could still be observed in unencapsulated pneumooccal mutants3. This suggests that factors other 
than capsule are likely to make an important contribution to this phenomenon.
Although the phenomenon of phase variation has been clearly demonstrated in S. pneumoniae, there is dis-
cordance in the literature regarding the contribution of protein expression patterns to colony opacity3, 7, 11. We 
reasoned that this could have been due to the fact that the pneumococcal strains and analytical techniques in 
each of those studies were quite different. Therefore, in order to gain further insight on the nature of proteins 
that might be central to the transition from nasopharygeal colonization to invasive disease, we have performed a 
detailed proteomic analysis of colony opacity phase variants in 3 S. pneumoniae strains with distinct pathogenicity 
characteristics (D39 [serotype 2], WCH16 [serotype 6A] and WCH43 [serotype 4]).
Cross comparisons of up to 20 up-regulated protein spots of O and T variants of the 3 strains show that there 
is very little overlap in the protein expression patterns between all 3 strains. The differentially-regulated proteins 
can generally be classified into five groups: those involved pyruvate metabolism, glycolysis to pyruvate produc-
tion, transcription/translation proteins, and those required to maintain cellular health and sugar/amino acid 
transport. Most of the proteins involved in pyruvate metabolism and transcription/translation were found to be 
up-regulated in the O variants, whereas the ABC transporters and those involved in glycolysis up to pyruvate 
were upregulated in the T variants. Four proteins involved in pyruvate metabolism were identified in this study 
as being differentially expressed between O and T variants of D39 and WCH16 – SpxB (up-regulated in D39O 
vs. D39T); formate acetyltransferase (up-regulated in WCH16O vs. WCH16T); bifunctional acetaldehyde-CoA/
alcohol dehydrogenase, AdhE (up-regulated in D39O vs. D39T); and lactate dehydrogenase, Ldh (up-regulated 
in WCH16T vs. WCH16O and in WCH43T vs. WCH43O).
Previous studies have shown that SpxB was differentially expressed protein between O and T variants of S. 
pneumoniae serotypes 4, 6B, 9 V and rough (unencapsulated) derivatives of D397, 21, 22, and it was significantly 
up-regulated only in D39O vs. D39T in this study. A plausible explanation for the observed differential expression 
of SpxB could be that more cell death occurs in the T variant during growth to A600 = 0.523. Cells at this density 
are in mid- to late-logarithmic growth phase whereby some SpxB is released into the medium, which would not 
be quantified from cell lysates used in the proteomic analysis. Interestingly, there was no detectable difference 
in SpxB expression between the O and T variants of any of the 3 strains by quantitative Western blotting. SpxB 
is known to exist in isoforms when run on a 2D-gel24, thus, if all the isoforms were quantified in all variants of 
the 3 strains, there may not be an overall significant change in SpxB expression. Other likely explanations for the 
discrepancies in SpxB expression by O and T variants between studies could be due to differences in the pneu-
mococcal strain, growth media and cell density. For example, Overweg et al.7 used a serotype 9 V strain (strain 
p10) and grew the bacteria in THY to A550 = 0.3 (early to mid-logarithmic phase) compared to D39 (serotype 2), 
WCH43 (serotype 4) and WCH16 (serotype 6A) grown in C + Y to mid- to late-logarithmic phase in this study.
In order to further investigate the role of SpxB in pneumococcal phase variation, spxB was deleted in strain 
D39 which resulted in a larger and hyper-opaque phenotype as documented in other studies11, 21, 25–27. This, in 
part, could be attributed to an increase in capsule production11 or could be a consequence of reduced production 
of hydrogen peroxide and thus an increase in biomass production over time as a result of decreased cell death. 
However, it is unlikely that reduced SpxB expression is the switch that determines pneumococcal opacity pheno-
typic variation, as ectopic over-expression of SpxB in the O variant did not result in a T phenotype. Furthermore, 
when the spxB gene from either O or T variant was transformed into D39O and D39T spxB mutants, the trans-
formants reverted back to their respective WT phenotypes, regardless of the origin of the spxB gene. This suggests 
that the spxB gene itself is not responsible for the change in pneumococcal colony opacity variation, but rather, it 
can act in concert with other proteins to generate the different colony opacity phenotypes.
Our proteomic analysis also revealed that GAPDH was significantly up-regulated in the T variants of D39 
and WCH43, but not in WCH16, and this was confirmed by GAPDH activity assays. This would suggest that in 
the T variants, increase in GAPDH activity results in carbon metabolic flux being directed to the production of 
pyruvate and generation of ATP during glycolysis. Consistent with this is a significant increase in expression of 
Ldh (which converts pyruvate to lactate) in the T variants of the 3 strains, confirming a role for this enzyme in 
maintenance of redox balance in pneumococcal central metabolism28.
Conclusions
The findings of the proteomic analysis of the O and T variants of 3 pneumococcal strains examined in this study 
suggest that a combination of metabolic activities and overall protein expression patterns contribute to the O and 
T phenotypes, and that these opacity variations are likely strain dependent. Thus, it is unlikely that there is one 
Strain
GAPDH activity 
T/O ± SEM p-value (t-test)
D39 1.50 ± 0.12 p < 0.001
WCH16 0.87 ± 0.17 ns
WCH43 1.49 ± 0.17 p < 0.05
Table 1. GAPDH activity of pneumococcal variants. The activity of three biological replicates of each strain 
(D39, WCH16 and WCH43) was calculated over the linear portion of the graph and expressed as a mean 
relative to the opaque variant of that strain.
www.nature.com/scientificreports/
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single protein that switches the pneumococcus from O variant to T variant, and vice versa. Rather, it suggests that 
opacity phase variation in S. pneumoniae is complex and multifactorial, requiring a combination of factors and 
events that act together to produce a certain opacity phenotype that contributes to its pathogenicity characteris-
tics. For example, in vivo, D39 and WCH43 are more likely to cause bacteremia where the O variant is more com-
monly isolated, while WCH16 is more adept at colonizing the nasopharynx, a niche where T variants are more 
commonly isolated. This might explain why the protein expression profiles of D39 and WCH43 are more similar 
to each other than to that of WCH16. The proteins that are up-regulated in the T variant, such as PhtD, appear 
to be those involved in adherence, while those up-regulated in the O variant include stress proteins, those that 
are associated with virulence, such as PurA, or those required for repair of the cell as it encounters more stresses 
during invasion, such as host immune cells present in the blood.
Methods
Bacterial strains and growth conditions. The pneumococcal strains used in this study are serotype 2 
(D39; Sequence Type [ST] 595), serotype 4 (WCH43; ST205), and serotype 6A (WCH16; ST4966). Serotype-
specific capsule production was confirmed by Quellung reaction, as described previously29. Pure opaque (“O”) 
and transparent (“T”) phase variants from minimally passaged frozen stocks of the three strains were selected 
after growth on Todd-Hewitt broth supplemented with 1% yeast extract (THY)-catalase plates and observed under 
oblique, transmitted light as described previously3. Aliqouts of each phenotypic variant of all strains were frozen 
at −80 °C and confirmed to be pure by several in vitro passages on THY-catalase plates; these served as working 
stocks for subsequent experiments. Cell pellets were prepared by growing the strains in C + Y broth30 to A600 = 0.5 
approx. 1 × 108 colony-forming units [CFUs], an aliquot was plated on THY-catalase plate to confirm purity, while 
the rest of the culture was centrifuged at 10,000 ×  g for 10 min and the pellet frozen at −80°C until required. For 
proteomic analyses, each phenotypic variant of each strain was grown on four separate occasions to obtain quad-
ruplicate samples for analysis. Samples were lysed in protease inhibitor cocktail tablet [Roche Diagnostic], 1 μg/ml 
DNase I [Roche], 1 μg/ml RNase A [Roche] and 100 U/ml mutanolysin [Sigma] and disrupted using an Aminco 
French Pressure Cell at 12,000 psi. Lysates of O and T variants of strains D39, WCH16 and WCH43 were separated 
into membrane and cytosolic fractions by ultracentrifugation at 255,000 × g for 1 hour at 4 °C.
2D-DIGE Procedures. Chemicals and Solvents. Urea, ammonium bicarbonate and acetonitrile (ACN) 
were obtained from Merck (Darmstadt, Germany); thiourea, CyDyes, iodoacetamide (IAA) and Pharmalyte 
Figure 7. Quantitative Western blotting of pneumococcal proteins from lysates of opaque and transparent 
variants of D39, WCH16 and WCH43. Data are fluorescence intensity of the protein-reactive species, relative 
to that of the PsaA loading control for each strain (mean ± SEM of quadruplicate experiments). *P < 0.05; 
**P < 0.01; unpaired t-test, two-tailed.
www.nature.com/scientificreports/
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3–10 were obtained from GE Healthcare (Little Chalfont, UK); 3-[(3-cholamidopropyl) dimethylammo-
nio]-1-propanesulfonate (CHAPS) was purchased from Roche Diagnostics (Basel, Switzerland). The EZQ protein 
quantification assay was from Life Technologies (Carlsbad, USA). Equilibration buffer and Electrode solutions 
for SDS-PAGE were obtained from Serva (Heidelberg, Germany). Dithiothreitol (DTT), Hydroxyethyldisulfide 
(HED), dimethylformamide (DMF), formic acid and L-lysine were purchased from Sigma-Aldrich (St. Louis, 
USA). The ReadyPrep 2D clean up kit was obtained from Bio-Rad (Hercules, USA). Sequencing grade modified 
trypsin was purchased from Promega (Finchburg, USA). All buffers were prepared using ultra-pure water from a 
Thermo Fisher Scientific system (Waltham, USA).
DIGE labelling. Two sets of DIGE experiments were performed. The first set consists of three independent DIGE 
experiments using O and T variants of strains D39, WCH16 and WCH43, respectively (Supplementary Table S5). 
The second set used the variants of all the 3 strains in a combined DIGE approach (Supplementary Table S5). The 
three powdered CyDyes were resuspended in DMF, aliquoted in 1 μl volumes (200 pmol CyDye) and stored under 
argon at −80 °C until required. Before labelling, equal protein amounts of the respective cytosolic and membrane 
fractions were mixed. Thereafter, 200 pmol of either Cy3 or Cy5 dye was added to the individual mixtures of 
cytosolic and membrane fractions. The internal pooled standard (IPS) was prepared by pooling equal protein 
amounts of each sample applied in this study and labelled with 200 pmol Cy2 dye per 100 μg of protein. After 
labelling, DTT solution (0.167 g DTT/100 μl H2O) and Pharmalyte 3–10 were added to each sample, both to an 
individual final volume of 2% (v/v). The samples were then subjected to isoelectric focusing.
Isoelectric focusing (IEF). IPG strips with a non-linear pH gradient from 3–11 and a length of 24 cm (GE 
Healthcare) were rehydrated overnight in 450 μl TUC1% (6 M Urea, 2 M Thiourea, 50% ACN, 1% CHAPS, 0.5% 
Pharmalyte 3–10, 200 mM HED), samples were applied to the IPG strips via anodic cup-loading and IEF was 
performed according to published protocols31 on a IPGphor II (GE Healthcare) in darkness. The IEF was stopped 
after 27,000 Vhrs.
SDS-PAGE. The IPG strips were equilibrated in the dark according to the protocol of Serva. Electrophoresis 
was carried out on T = 12.5% precast polyacrylamide gels (Serva) using an Ettan DALT 12 electrophoresis unit 
(GE Healthcare) according to the protocol of Serva. For the independent DIGE experiments of D39, WCH16 
and WCH43, SDS-PAGE in the DIGE experiment combining all variants was carried out on T = 12.5% precast 
polyacrylamide flatbed gels (Serva) using the HPE FlatTop Tower unit (Serva) according to the manufacturers 
protocol.
DIGE Imaging and analysis. SDS-PAGE gels were scanned using an Ettan DIGE Imager (GE Healthcare) with 
a resolution of 100 μm. The exposure times of the individual channels (Cy2, Cy3 and Cy5) were set to yield a 
maximum of approximately 35,000 intensity units. The resulting images were horizontally flipped before image 
analysis using ImageQuant TL (Version 7.0, GE Healthcare).
Image analysis was undertaken using DeCyder 2D software (version 7, GE Healthcare). Each gel image was 
processed separately in the Differential In-gel Analysis (DIA) module of DeCyder prior to export to the Biological 
Variation Analysis (BVA) module. In all DIGE experiments, protein expression in the T variant of every strain was 
subjected to statistical comparison with its O counterpart (D39O vs. D39T; WCH16O vs. WCH16T; WCH43O 
vs. WCH43T) to detect spots that are differentially expressed using unpaired two-tailed Students t-test. Those 
spots that returned a p-value of <0.05 were accepted. For the second DIGE experiments, spots with a significant 
p-value were further verified to exhibit a consistent regulation pattern, i.e. up/down regulated in T vs. O in all 
three strains.
Protein identification. For the first DIGE set, 500 μg of protein consisting of equal amounts of the cytosolic 
and membrane fractions of the respective T and O variant of each strain were pooled and separated according 
to the protocols described above (omitting the labelling reaction). After SDS-PAGE, the gels were fixed using 
40% ethanol and 10% acetic acid and proteins stained afterwards using Coomassie brilliant blue. The proteins of 
interest were picked manually, ensuring the correct spot identity by comparison of the DIGE derived spot pattern 
with the spot pattern on the Coomassie brilliant blue stained gel. Liquid chromatography electrospray ionisation 
ion-trap mass spectrometry (LC-ESI-IT MS) using an HTC Ultra 3D ion trap (Bruker Daltonics) was performed 
as detailed in Supplementary Information. For the second DIGE set of experiments, the proteins of interest were 
excised from the DIGE gels using an Ettan Spot Picker (GE Healthcare). To account for the lower protein loading 
in the DIGE gels relative to that of the Coomassie stained gels, the proteins were identified using a LTQ Orbitrap 
mass spectrometer (Thermo Fisher). Liquid chromatography-mass spectrometry (LC-MS) with the Orbitrap was 
performed using a Shimadzu Prominence LC-20AD nano HPLC (Shimadzu, Japan) and Mass Spectrometer, 
coupled using the Nanospray Source I (Thermo Fisher Scientific) and a nanospray emitter (NewObjective, MA).
Mass spectrometry data analysis. For HTC ion trap MS, DataAnalysis (Version 3.4, Bruker Daltonics) was used 
to perform peak detection and de-convolution of the MS and MS/MS spectra. The derived compound lists were 
exported into BioTools (Version 3.1, Bruker Daltonics) then submitted to Mascot (Version 2.2, Matrix Science). 
For LTQ Orbitrap MS, data analysis was performed using the XCalibur software (Version 2.0.7, Thermo Fisher 
Scientific). MS/MS spectra were extracted and submitted to the Mascot search engine using Proteome Discoverer 
(Version 1.3, Thermo Fisher Scientific).
Over-expression of SpxB. The overexpression of spxB in the O variant of D39 was achieved 
by cloning the spxB gene from the T variant of D39 into a modified Streptococcus-Escherichia coli 
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shuttle vector pVA838 [pAL3]32, which had been engineered to express spxB genes under the S. pneu-
moniae aminopterin resistance operon (ami) promoter33. To generate spxB-expressing plasmid 
(pAL3:spxB), spxB-specific forward (5′-TCCAATTCTATGTAATCGAATTCTCCAAG-3′) and reverse 
(5′-GAAAATCAAAGAATGAATTCTACAAGTTTC-3′) primer sequences carrying EcoRI sites were used to 
PCR-amplify spxB (1.8 kb) from a D39T DNA template, and cloned into the corresponding EcoRI-digested and 
dephosphorylated site in pAL3. The ligation mixture was initially used to transform competent E. coli XL-10 after 
which the recombinant plasmid was extracted and confirmed to be of the right size and orientation. The resultant 
pAL3:spxB clone was then used to transform the O variant of D39 essentially as described previously32.
GAPDH activity assays. In order to measure the GAPDH activity of the various O and T variants cell pel-
lets were resuspended in 1 ml PBS, disrupted by sonication and clarified at 13,000 ×  g for 10 min at 4 °C. Extracts 
were kept on ice until required. The GAPDH assay was a measurement of the reduction of NAD (β-Nicotinamide 
adenine dinucleotide hydrate) according to Fillinger et al.34, with modifications. Using a 1 ml disposable cuvette, 
900 μl triethanolamine/sodium arsenate buffer (125 mM triethanolamine [Sigma], 5 mM L-cysteine [Sigma], 
20 mM sodium arsenate [Sigma], 50 mM disodium hydrogen phosphate, Na2HPO4 [Merck], pH 9.2), 2 mM 
NAD [Sigma] and 60 μl cell extracts were mixed and read at A340nm at 25 °C. Initially, the mixture was allowed 
to react for about 10 seconds to ensure that there is nothing in the solution reducing the NAD. Thereafter, 4 mM 
D-glyceraldehyde-3-phosphate, G-3-P (substrate) [Sigma] was added and the reaction was recorded for 3–5 min-
utes. One unit causes an initial reaction of reduction of one micromole of NAD per minute and is calculated as 




Units per mg A340 nm per minute
6 22 mg enzyme per ml reaction mixture
The amount of GAPDH was then calculated relative to the O variant of each strain. Data were analysed using 
Student’s unpaired t-test.
Quantitative Western blotting. Relative protein expression was determined by quantitative Western 
blotting of whole cell lysates of S. pneumoniae O and T variants and their recombinant derivatives. Briefly, pneu-
mococci were grown to A600nm = 0.19 in SB or A600nm = 0.5 in C + Y, concentrated 40-fold and lysed by treatment 
with 0.1% [w/v] DOC. The total protein in the lysates was determined using the BCA Protein Assay kit [Thermo 
Scientific]. Approximately 15 μg of the lysates were resuspended in lysate buffer (2.5% [v/v] β-mercaptoethanol, 
31.25 mM Tris-HCl, 1% [w/v] DOC, 5% [v/v] glycerol, and 0.025% [w/v] bromophenol blue; pH 6.8) and sub-
jected to SDS-PAGE. Separated proteins were electro-blotted onto nitrocellulose membrane [Invitrogen] using 
the iBlot Dry Blotting System according to the manufacturer’s instructions [Invitrogen], and then probed with 
a 1:5,000 dilution of target mouse-polyclonal antiserum (primary antibody) in assay buffer (Tris buffered saline 
containing 0.02% Tween 20 [TTBS]). After extensive washing TTBS, the blot was reacted with donkey anti-mouse 
IRDye 800 CW secondary antibody [LI-COR Biosciences, Nebraska, USA] at a dilution of 1:50,000. The blot was 
scanned using the Odyssey Infrared Imaging System [Li-COR Biosciences]. Relative quantification of protein 
expression between the strains was performed using the Odyssey Infrared Imaging System application software 
v 3.0.21 by comparing units of fluorescence [LI-COR Biosciences]. Purified recombinant protein was used as a 
marker for each protein of interest, and reactivity to recombinant PsaA was used as a loading control.
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